A biosimilar medicine is a biological medicine that is developed to be highly similar and clinically equivalent to an existing biological medicine. A biosimilar contains a version of an active substance of an already approved biological medicine, which is referred to as the ‘reference medicine’ or ‘originator medicine’. A biosimilar item is a natural item that is endorsed in light of a demonstrating that it is profoundly like a FDA-approved biologics, known as a kind of perspective item, and has no clinically significant contrasts as far as wellbeing and viability from the reference item. Just minor contrasts in clinically insignificant parts are reasonable in biosimilar items. A strict regulation is needed to encircle all the activities concerning biosimilars. Different countries have different regulation for the biosimilars to ensure a safe and effective medicine at lowest price.